Nano-X Imaging Ltd. ( (NNOX) ) has released its Q4 earnings. Here is a breakdown of the information Nano-X Imaging Ltd. presented to its investors.
Nano-X Imaging Ltd., a medical imaging technology company, focuses on providing affordable imaging solutions using advanced AI and digital X-ray sources, primarily in the healthcare sector.
In its latest earnings report for the fourth quarter of 2024, Nano-X Imaging Ltd. highlighted significant regulatory achievements, including FDA clearance for general use of its Nanox.ARC system and a CE mark in the EU. The company also expanded its global commercialization efforts by signing new agreements with customers and channel partners.
Financially, Nano-X reported a revenue increase to $3.0 million in Q4 2024 from $2.4 million in the same period the previous year. Despite this growth, the company faced a net loss of $14.1 million, up from $10.2 million in Q4 2023, mainly due to a one-time income recognized in the previous year. The company also noted improvements in its teleradiology services, which contributed $2.8 million to the revenue with increased gross profit margins.
Looking ahead, Nano-X Imaging Ltd. remains optimistic about its position in the medical imaging market, aiming to leverage its innovative technologies to enhance accessibility and reduce costs in healthcare delivery. The company is poised to continue its momentum into 2025, focusing on expanding its technological portfolio and market presence.